Search

everythinglearnresearchcommunity

for

Search:↓

Some patients on Baricitinib for alopecia areata lost response, often linked to longer and more severe initial conditions.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

The hydrogel helps heal diabetic wounds by combining antibacterial, antioxidant, and immune-boosting effects.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

The dressing helps heal chronic wounds by swelling and releasing drugs when needed.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Pranlukast and mirabegron may work as new diabetes drugs.

Selumetinib causes fewer and less severe skin issues in children than binimetinib.

Five existing drugs may help fight Swine Acute Diarrhea Syndrome Coronavirus.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Dutasteride is approved to help manage prostate enlargement.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

Sorafenib can cause a unique skin reaction.

Thymosin β4 helps with healing, inflammation, and organ protection.

A new treatment for hair loss shows promise with fewer side effects.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.